Ectopic pregnancy
-
Upload
priyadharshini-manickam -
Category
Science
-
view
114 -
download
2
Transcript of Ectopic pregnancy
Dr. PRIYADHARSHINI M
Definition
Any pregnancy where the fertilized ovum gets implanted & develops in a site other than the normal endometrial cavity.
Serious hazard to a woman’s health and reproductive potential, requiring prompt recognition & early aggressive intervention
Ovulation ovum picked up by fimbria swept by ciliary action towards ampulla fertilization.
Zygote cleavage division in (3 -4 days) morula (8-32 cell stage)embryo to uterine cavity for up to 72 hours D6 enters uterusimplantation- uterine cavity in normal positioned pregnancy .
hCG (trophoblast)mother’s serum 1 week after implantation, level doubles every 36-48 hours
Delay or obstruction of the passage of fertilized egg down the fallopian tube to the uterusimplantation in tube or ovary or peritoneal cavityectopic pregnancy
Eventually fails to develop
hCG fails to raise dramatically
1-2 % of total pregnancy
Recurrence rate – 15% after 1st, 25% after 2 ectopics
Increasing incidence
4th leading cause of maternal mortality overall (4%)
MC cause of maternal mortality I trimester
Types:
1. Tubal(95-98%)
2. Non tubal(2-5%)
3. Heterotropic(1/1000)
IMPLANTATION SITES
TUBAL
(97%)
AMPULLARY 70%
INFUNDIBULAR
11%
INTERSTITIAL
2%
ISTHMUS 12%
ABDOMINAL
(0.1)
SECONDARY
INTRAPERITONEAL
MC
EXTRAPERITONEAL
(broad lig)
PRIMARY
(rare)
OVARIAN
(0.5)
EXTRA
UTERINE
UTERINE
(1.5)
ANGULAR
CERVICAL <1%
CORNUAL
CS SCAR <1%
Improved technology
The rising incidence of risk factors-
acute & chronic salpingitis
induced abortion
tubal ligation
tubal reconstructive surgery
ART
Conservative management of tubal pregnancy,
Congenital: long narrow tube, diverticulae , accessory ostia.
Traumatic: operation on the tube –salpingoplasty ,tubal reversal following ligation.
Inflammatory: Chronic salpingitis
Neoplastic: Narrowing of the tube by a fibroid or a broad ligament tumor.
Functional: As tubal spasm or antiperistalticcontractions.
Endometriosis in the tube. encourages embedding of the fertilized ovum.
Separation of the gestational sac from
the tubal wall
Degeneration
Fall of hCG level,
Regression of the corpus luteum
Drop in the oestrogen & progesterone level
Separation of the uterine decidua with uterine bleeding
Risk Factor Risk %
High Risk
PID *
Tubal corrective surgery
Tubal sterilization
Previous EP
In utero DES exposure
IUD **
Documented tubal
pathology
Moderate Risk
Infertility
Previous genital infection
Multiple partners
Slight risk
Previous pelvic or
abdominal surgery
Smoking
Douching
Intercourse before 18 years
25
21.0
9.3
8.5
5.6
4.2-45
3.8-21
2.5-21
2.5-3.7
2.1
0.93-3.8
2.3-2.5
1.1-3.1
1.6
Up to half of women with ectopic pregnancy will have no identifiable risk factors.
Use of assisted reproductive technology (such as IVF and GIFT)
•7 fold risk after acute pelvic infection
** 4 times risk- increased protection against IU pregnancy, increased incidence of PID
RISK FACTORS
Infections chlamydia, gonorrhoea
Damage to ciliated surface of endosalpinx
intratubaladhesions partial tubal obstruction
peritubaladhesions restricted tubal motility
Alteration of tubal transport mechanisms
slow the passage of egg time to implant itself in the tube
1- Tubal mole:
sac is surrounded by blood clot & retained
chronic ectopic pregnancy/ involution
2-Tubal abortion: ampullary
Separation of sac expulsion into peritoneal cavity through ostium.
Rarely, reimplantation of conceptus occurs in another abdominal structure secondary abdominal pregnancy.
3-Tubal rupture: isthmus
Rupture in anti-mesenteric border profuse bleeding →intraperitoneal haemorrhage.
rupture in mesenteric border broad ligament haematoma.
Tubal abortion
OUTCOMES
Tubal Rupture
16
•Extraperitoneal rupture (rupture through floor of the tube)broad ligament hematoma with death of the ovum, intraligamentary pregnancy.
The diagnosis often presents great difficulty
Usually missed because it is NOT suspected.
“Pregnancy in the fallopian tube is a black cat on adark night. It may make its presence felt in subtleways and leap at you or it may slip past unobserved.Although it is difficult to distinguish from cats ofother colours in darkness, illumination clearly
identifies it.”
- Mc. Fadyen - 1981
Multimodality approach including
Proper history (cycle, pregnancy, PID,infertility, gynaecological surgery, contraception)
Clinical examination (Proper general, abdominal, vaginal and vital signs)
Judicious use of investigation
Wide spectrum of presentation from asymptomatic pt to others with acute abdomen and in shock
Early symptoms - either absent/ subtle.
7.2 weeks after LMP (range 5-8 weeks)
ECTOPIC
ABNORMAL VAGINAL BLEEDING70%
ABDOMINAL PAIN
Most common
AMENORRHOEA75%
Apart from classical triad pt presents with
Features of shock
Danforth sign, cullen sign
P/A-Abdominal tenderness,guarding,BSdecreased/absent
P/S-Minimal bleeding
P/V-Uterus bulky,fornix tender full,pod full,adnexalmass, cervical motion tenderness ”JUMPING SIGN”
Bimanual examination should be very gentle with facilities for immediate surgical intervention if needed
H/O-acute attack of pain from which she has recovered
O/E-ill looking without any features of shock
P/A-irregular mass,tenderness
P/S-vaginal mucosa pale
P/V-uterus may be normal/bulky,ill defined mass may be felt through fornix
Difficult to diagnose and high degree of clinical suspiscion is needed,sometimes diagnosed accidentally during laparoscopy/laparotomy
C/F-Delayed periods,spotting with lower abdominal discomfort
P/A-tenderness in lower abdomen
P/V-Uterus normal size,small tender mass may be felt in the fornix
DIFFERENTIAL
DIAGNOSISDDX
Appendicitis (Perforated)
Acute Pancreatities
Myocardial Infarct
Pelvic Abcess
Splenic Rupture
Perforated Gastric or Duodenal Ulcer
(1) NON GYNECOLOGICAL
Septic Abortion
Threatened Abortion
Pyosalpinx
Pelvic Abcess
Twisted Ovarian Cyst
Acute pelvic inflammatory
disease
Rupture of Follicle or
Corpus Luteum Cyst
Degenerating leiomyoma
Retroverted Gravid Uterus
(2) GYNAECOLOGICAL
•Accuracy of initial clinical evaluation < 50%.
General investigations Urine pregnancy testCuldocentesisTransvaginal ultrasonographySerum beta hcgUrine beta hcgSerum progesteroneUterine currettageLaparoscopy/laparotomy
Presence of free flowing nonclotting bloodintraabdominalhaemorrhage
serous fluid negativeLack of fluid
return/clotted bloodnon- diagnostic
Negative culdocentesisdoes not exclude chance of ectopic
UPT not always positive Serum β-hCG (ELISA / RIA) detects very early pregnancy
about 10 days after fertilization i.e. before the missed period.Discriminatory zone: 1000-2000 IU/L TVS; 5000-6000 IU/L TASAbsence of uterine pregnancy abnormal pregnancy( ectopic,
incomplete abortion) β-hCG levels still below the discriminatory value, serial β-Hcg
USG should be done.Doubling sign: Normal : >66% increase levels every 48 hours (nearly 2X). Inappropriately rising serum β-hCG levels suggest (but do not
diagnose) abnormal pregnancy including ectopicDo not identify its location.
Specificity 94%,sensitivity 38%
TVS superior to TAS
Failure to see Gestational sac at 4-5 wks gestation and at beta hcg 1500iu/l i.e. the discriminatory zone
Observation of g.sac, embryo, cardiac activity outside the uterus
In some cases no sac is found either intrauterine/extrauterine
7-20% proved to be ectopic
25% of ectopic presents with PUL
Intrauterine pregnancy in which the sac is not developed, collapsed or aborted.
Ectopic too small to be detected
Transvaginal USG
Positive β-hCG test + empty uterus by sonar ±adnexal mass Ectopic pregnancy.
Endometrial cavity shows trilaminar echo pattern
Identification of double decidual sac sign(DDSS) is the
best method to differentiate true sacs from pseudosacs
Pseudogestational sac seen formed by the sloughing of decidua creating an intracavitary fluid collection.it differs from true g.sac in having only one layer and midline location where as true sac is usually eccentric
Decidual cast sometimes seen
Decidual cyst anechoic area at the endometrium-myometrium border
Pouch of douglas may contain free fluid
Presence of corpus luteal cyst in ipsilateral ovaries is a useful marker
Appx 60%-seen as inhomogenous mass/blob sign adjacent to ovary, moving separetely from it
Appx 20%-as adnexal hyperechoic ring/bagel sign (fluid sacs with thick echogenic ring)
Appx 13%-as obvious gestational sac with fetal pole/cardiac activity
Doppler improve the accuracy & identify the placental
shape ( ring of fire pattern) & blood flow outside the
uterine cavity
Value >25ng/ml normal intrauterine pregnancy
Value<5ng/ml nonviable intrauterine pregnancy/ extrauterine pregnancy
Most of ectopic pregnancy value ranges 10-25 ng/ml
Diagnostic laparoscopy
Gold standard
for diagnosis of
ectopic pregnancy
Diagnosis &
removal of ectopic
mass can be done
at the same time
Presence of villi excludes ectopic pregnancy not heterotopicpregnancy
Absence of villi and presence of Ariastella reaction suggests ectopic pregnancy
OTHERS- VEGF, CA125, creatinekinase, fetal fibronectin, placental protein, Estradiol, maternal AFP, relaxin
Suspected ectopic
UPT+
S/S STABLE
ECTOPIC Non diagnostic
Serum beta HCG
>1500
CURETTAGE
VILLI
ABORTION
NO VILLI
<1500
Repeat B HCG
Intrauterine pregnancy
ABORTION
TVS
UNSTABLE
SURGICALMANAGEMENT
1• EXPECTANT MANAGEMENT
2• MEDICAL MANAGEMENT
3• SURGICAL MANAGEMENT
4• EMERGENCY MANAGEMENT
EXPECTANTMANAGEMENT
1
Criteria for selection (RCOG-green top-21-guideline)
Asymptomatic pt
Hemodynamically stable
<100 ml fluid in the pouch of Douglas
Lower beta hcg value<1000 IU/ml
Adnexal mass <3cm without cardiac activity
Pregnancy of unknown location
They must be fully compliant and must be willing to accept the potential risks of tubal rupture.
• Success rate is 60% with decreasing beta hcg titre
Initial follow up
twice weekly with serial Hcg measurements
weekly by TVS
By the first week
drop in HCG level
Adnexal mass size
Otherwise reassess the options (Medical/Surgical)
If the fall of HCG & reduction in size of adnexalmass satisfatory
weekly hCG & TVS till HCG falls <20 IU
MONITORING
45–70% of PUL resolve spontaneously with expectant management
Ectopic pregnancy was subsequently diagnosed in 14–28% of PUL
Intervention(laparoscopic salpingostomy) has been shown to be required in 23–29% of cases
MEDICAL
2
CRITERIA FOR MEDICAL MANAGEMENTS
elec
tio
n c
rite
ria Minimal symptoms/
hemodynamically stable
No signs or symptoms of active bleeding / haemoperitoneum.
HCG<3000(RCOG)
Normal CBC,RFT,LFT
Size<4cm
Absence of cardiac activity
Persistent ectopic after conservative surgery
Good compliance and follow up can be assured(RCOG)
Women should be given clear information(preferably written)about the possible need for further Tt and adverse effects following Tt (RCOG)
Exc
lusi
on
cri
teri
a Any hepatic dysfunction, thrombocytopenia (<100,000), blood dyscrasia(WBC <2000).
Difficulty/unwillingness of patient for prolonged follow-up (avg follow-up 35days).
Ectopic mass >4cm
presence of cardiac activity
Women on concurrent corticosteroid therapy
• Methotrexate
SYSTEMIC
( IV, IM or orally )
• RU-486
• PgF2 alpha, MTX
• KCl , hyperosmolar glucose
• Actinomycin D
LOCALLYSALPHINGOCENTESIS
(laparoscopic direct injection, retrograde
salpingography)
Other agents- not recommended because their safety & accuracy are not
well documented
Advantage:
Increased conc at local site
lesser systemic s/e
Increased fertility
Shorter hospital stay
Follow up:
Beta hcg twice wkly till<10iu/l
TVS weekly till 4-6 wk
Hcg after 6 month
Methotrexate:
folic acid antagonist inhibits DHFR enzyme thus depleting the stores needed for DNA/RNA synthesis during trophoblast proliferation
first used by Tanaka et al(1982)-interstitial ectopic pregnancy
Methotrexate-IM(buttock or lateral thigh)
Prior tests- CBC,LFT,RFT,CXR repeated after 1 week
1.Multidose regimen –
MTX 1mg/kg IM on 1,3,5,7 days
Leucovorin 0.1mg/kg on 2,4,6,8 days
Measure B-hCG levels on days 1,3,5,7 until 15% decrease between 2 measurement
Once B-hCG level drops 15%, stop MTX & monitor B-hCG weekly until non pregnant level
2.Single dose regimen:
MTX 50mg/m2 on day 0
Measure B-hCG level on days 4 & 7
If level drops by 15%, monitor B-hCG weekly until non pregnant level. If levels do not drop by 15%, repeat dose of MTX & measure B-hCG on days 4 & 7
87% success rate
Advantages:
Increased pt compliance
Simplified administration
Safe & effective
Less expensive
Less monitoring
3.Two dose regimen:
MTX 50mg/m2 on days 0 & 4
Measure B-hCG levels on days 4 & 7
If levels drop by 15%, monitor B-hCG weekly until non pregnant level
If level do not drop by 15%, repeat dose of MTX on days 7 & 11 & measure B-hCG on days 7 & 11. If levels drop 15%, monitor B-hCG level weekly until non pregnant level
UNTOWARD EFFECTS:
Dose & frequency dependent
(30-40%)
nausea, vomiting
Stomatitis,
abdominal pain
bone marrow suppression
Alopecia
dermatitis & pneumonitis.
Deranged LFT
Rest up to one hour after the injection. local reaction- anti-histamine/ steroid cream (v.rare)
use reliable contraception for 3 months after MTX (barrier or hormonal)
Avoid
sexual intercourse during treatment
exposure to sunlight.
alcohol , vitamin preparations containing folate until the hormone level is back to zero.
aspirin or drugs such as Ibuprofen for one week after treatment.
FOLLOWED UP for signs of tubal rupture-( severe pain/unstable/falling Hct)- surgical intervention
90% successful treatment with single dose regime.
10 – 20%. Recurrent ectopic pregnancy rate
80%. Tubal patency rate
75% abdominal pain-separation pain.(D3-D7)
14 % of medical management 2nd dose of MTX
10% finally require surgical management
Risk of subsequent ectopic 10% following either MTX(MD)/salpingostomy.
similar reproductive outcomes
Success rates(time to resolution ) correlates with initial serum B HCG
OUTCOME
Medical management- cheap initially
but considering the cost of follow up & the loss of work time for patient & carers no cost saving was seen at serum hCG levels above 1500 iu/l
SURGICAL
3
Not a suitable candidate for medical therapy.
Failed Medical therapy.
heterotropic pregnancy with viable intrauterine pregnancy.
hemodynamically unstable & needs immediate treatment.
Surgical approachlaparoscopy or laparotomy
hemodynamic stability
size & location of ectopic mass
surgeons expertise
Quick in and Quick out - principle
Conservative & extirpative
Linear salpingostomy:
<2cm size, in distal third of tube
Antemesenteric border incised –heals by secondary intention
FOLLOW UP
iND
ICA
TIO
NS
• unruptured ampullaryectopic pregnancy(toc),
• wishes to retain potential for future fertility
• affected fallopian tube otherwise normal
• Contralateral tube appears damaged
CO
NT
RA
IND
ICA
TIO
NS
Ruptured tube
use of extensive cauteryto obtain hemostasis
severely damaged tube
recurrent ectopic pregnancy in same
tube.
Salpingotomy
Conservative surgical management
Incision – closed with vicryl7-0
ectopic has not ruptured
the tube appears normal
Segmental resection and anastomosis: for unrupturedisthmic pregnancy
Milking /fimbrial expression: infundibular pregnancy, best reserved when products protrude out.
2X recurrence
EXTIRPATIVESalpingectomy (PARTIAL/TOTAL)
Salpingectomy (tubal removal) is the principle treatment especially where there is tubal rupture
wedge area of outer 3rd of interstitial portion of tube is also resected ,known as cornual resection to minimise occurence of pregnancy in tubal stump
Total salpingectomy is the procedure of choice: completed childbearing and no longer desires fertility history of an ectopic pregnancy in the same tube. severely damaged tubes
Cumulative inrauterine pregnancy rates and also incidence of recurrent ectopic – higher with salpingostomy
Salpingectomy Salpingotomy
• There may be a higher subsequent intrauterine pregnancy rate associated with salpingotomy but the magnitude of this benefit may be small
• Trend towards higher subsequent ectopic pregnancy
• small risk of tubal bleeding in the immediate postoperative period
• potential need for further treatment for persistent trophoblast
Salpingostomy
Chance of intrauterine pregnancy- 73%
Chance of recurrent ectopic- 15%
LaparoscopyTubal patency: 80-90%
Intrauterine preg: 55-75%
Recurrent ectopic: 10-15%
57%
10%
Laparotomy 80-90%
55-75%
10-15%
Salpingectomy
Laparotomy -
hemodynamically unstable and an expedited abdominal entry is required
patients with cornual , interstitial ectopics Extensive pelvic/abdominal adhesive disease surgeons inexperienced & patients where laparoscopic
approach is difficult
An alternative to laparoscopy is the use of minilaparotomy incision.-success rate similar
Laparoscopy
• Less intraoperative blood loss
• Shorter operation time
• Shorter hospital stay
• Lower analgesic requirement
• Future intrauterine pregnancy rate same
• Lower repeat ectopic pregnancy rate
Laparotomy
• Future intrauterine pregnancy rate same
• Preferable in the haemodynamically unstable patient
LAPROSCOPY
Tubal patency, future intrauterine pregnancy, future ectopic rates - no differences in laparoscopic salpingotomy and salpingostomy (recent cochranereview)
COMPARING systemic methotrexate with tube-sparing laparoscopic surgery, randomized trials have shown no difference in overall tubal preservation, tubal patency, repeat ectopic pregnancy, or future pregnancies(ACOG 2008)
Algorithm for the diagnosis of unrupturedectopic pregnancy without laparoscopy
ECTOPIC
RUPTURED
EMERGENCY
PRINCIPLE: Quick Resuscitation and simulataneous arrangement for laparotomy definitive surgery
ANTI SHOCK TREATMENT: ABC of resuscitation
give facial oxygen
Site two IV lines (at least 16g), commence IV fluids (crystalloid)
Send blood for CBC, Clotting screen and cross-match at least 4 units of blood.
- Folleys catheterization done
- colloids for volume replacement
whilst awaiting transfer to theatre continue fluid resuscitation and ensure intensive monitoring of haemodynamic state
LAPAROTOMY
- Rapid exploration of abdominal cavity done
- Salpingectomy (definitive surgery)peritoneal toileting
record operative findings including the state of the remaining tube/pelvis
Blood transfusion done
Anti D Ig (250 IU)given to Rh negative women
RCOG Guideline
factors affecting future pregnancy:
prior h/o of infertility (the most important)
treatment choice history ( whether surgical or nonsurgical)
For example, the rate of intrauterine pregnancy may be higher following methotrexate compared to surgical treatment.
Rate of fertility may be better following salpingostomy than salpingectomy.
Resorption/ tubal abortion- obviates need for further or medical management
Falling HCG(caution: tubal rupture can occur even with falling levels)
Low BHCG(<200mU/ml) 88%
Follow up with beta HCG
Complication of salpingotomy / salpingostomy(4-15%) when residual trophoblast continues to survive because of incomplete evacuation of ectopic pregnancy.
Mostly ruptures in post op So serial monitoring of beta hcg.(D1, every 3-7 days thereafter till
undetectable) Risks are small size<2cm, early preg<6wk, preop high
Bhcg>3000iu/l
Diagnosis : raised postoperative serum HCG If untreated, can cause life threatening hemorrhage
TREATMENT - IM / oral Methorexate single dose of 50 mg/m2 -TOC Reoperation and further evacuation / Salpingectomy
Pregnancy does not completely resolve after expectant mgt
Persistence of chorionic villi with bleeding into tubal wall slow distension , no rupture
Amenorrhoea, symptomatic pelvic mass, BHCG-low/absent, bowel/ureteral obstructive symptoms
DIAGNOSIS: USG
TREATMENT: Removal of affected tube, ovary removed
Non tubal pregnancy –types
Cervical(0.1-1%)
Ovarian(0.5-2%)
Abdominal(0.3-0.5%)
Interstitial(2-3%)
Angular
Cornual(1:1lakh)
Heterotropic
Multiple ectopic pregnancy
Ectopic in caesarean scar<1%)
Pregnancy after hysterectomy
Pregnancy occurs in the blind rudimentary horn of a bicornuate uterus.
As such a horn is capable of some hypertrophy and distension, rupture usually does not occur before 16-20 weeks.
Management -affected cornualpregnancy is removed hysteroscopicresection, hysterectomy
Thick section of tube- expands max capacity before rupture(7-16w)
2.4% of all ectopics
Late presentation rate
Most dangerous –torrential haemorrhage(dual supply)
mgt:
MTX – stable
Laparoscopic cornuostomy -unstable .
Hysteroscopic resection with selective arterial embolisation, Inj kcl
Hysterectomy(rupture)
• Uterus smaller than the surrounding distended cervix
• External os may be open
• Visible cervical lesion often blue or purple in colour
• Profuse bleeding on manipulation of cervix
Rubin1911
(following hysterectomy)
• Amenorrhoea painless bleeding
• Softened enlarged cervix to the size of uterine corpus
• Products of conception entirely confined & firmly attached to endocervix
• Closed internal os and partially open external os
PaalmanMcElin 1959
(Before hysterctomy)
Gestatational sac /placental tissue visualizd within cervix
Cardiac motion noted below the level of internal os
No intrauterine pregnancy’
Hourglass uterine shape with ballooned cervialcanal
No movement of sac with pressure from transvaginal probe(no sliding sign)
Closed internal os
Diagnosis
Clinical- painless vaginal bleeding/crampy pain
1/3massive harmorrhage
Very rarely>20 weeks
Imaging- USG: true cervical pregnancy vs ongoing spontaneous abortion: no sliding sign
MRI pelvis
D/D:
Carcinoma, cervical/prolapsed submucosal leiomyoma
Trophoblastic tumor
Placenta praevia
Evacuation and cervical packing with haemostatic agent as fibrin glue and gauze.
Lateral cervical suture placement
Cervical cerclage
Angiographic Arterial embolization
Laparotomy-uterine artery& internal iliac artery ligation
If bleeding continues or extensive rupture occurs hysterectomy is needed.
Cervical pregnancy-Management
Medical treatment with MTX,KCL
surgical dilation & curettage
feta
l ca
rdia
c
activity-
MultidoseMTX+KCL injection
MC type of non tubal ectopic
Aetiology:
* Pelvic adhesions.
* Favourable ovarian surface for implantation as in ovarian endometriosis.
Pathogenesis:
* Fertilization of the ovum inside the ovary or,
* implantation of the fertilized ovum in the ovary.
Spiegelberg criteria(1878)
* The gestational sac located in the region of the ovary,
* the ectopic attached to the uterus by the ovarian ligament,
* ovarian tissue in the wall of the gestational sac is proved histologically,
* the tube on the
involved side is intact.
Misdiagnosis very common(Ruptured corpus lutealcyst75%)
Laparotomy ovarian cystectomy/wedge resection for unruptured and oophorectomy for ruptured.
Treatment with MTX and prostaglandin injection has also been reported
primaryabdominal pregnancy
• Studifords criteria for diagnosis • Presence of normal tubes & ovaries with no evidence of recent or
past pregnancy
• No e/o uteroplacental fistula
• presence of a pregnancy related exclusively to the peritoneal surface & early enough to eliminate the possibility of secondary implantation after primary tubal nidation
Secondary
• usually after tubal rupture or abortion
• conceptus escapes out through a rent from primary site –Intraperitoneal or Extraperitoneal broad ligament
Intraligamentouspregnancy
• type of abdominal but extraperitoneal pregnancy. It develops between the anterior and posterior leaves of the broad ligament after rupture of tubal pregnancy in the mesosalpingeal border or lateral rupture of intramural (in the myometrium) pregnancy.
Diagnosis:
History: amenorrhoea an attack of lower abdominal pain & slight vaginal bleeding which subsided spontaneously., painful FM
Abdominal examination:
Unusual transverse or oblique lie.
Foetal parts are felt very superficial with no uterine muscle wall around.
Vaginal examination:
The uterus is soft, about 8 weeks and separate from the foetus.
Displaced uterine cervix
No presenting part in the pelvis.
Special investigations:
Plain X-ray: shows abnormal lie. In lateral view, the foetus overshadows the maternal spines .
Ultrasound: diagnoses only 40%,shows no uterine wall around the foetus
(MRI): has a particular importance in preoperative detection of placental anatomic relationships.
If pregnancy continues to termPerinatal mortality& morbidity is also increased(IUGR, congenital anomalies, fetal pulmonary hypoplasia, pressure deformities)maternal morbidity& mortality highly increased(7-8X, 50X)
laparotomy with removal of sac,fetus,placenta,membranes
placenta if attached to vital structures -left in situ
after ligating base
Placental involution serial USG, BHCG
MTX treatment contraindicated -high rate of complications due to rapid tissue necrosis
ANGULAR PREGNANCY
Implantation at lateral angle of
uterine cavity just medial to
uterotubal junction
In true sense not variety of
ectopic pregnancy
Confused with interstitial
pregnancyround ligament lies
medial to it.
intrauterine+ extrauterinepregnancy coexist
1:1001:30000
ART patients
Delayed diagnosis
Serial B HCG NOT useful
Surgical treatment of ectopic & intrauterine if desired Continue
Spontaneous abortion high
Newly highlighted
Prior CS csar, outside normal uterine cavity
Completely surrounded by myometrium & fibrous
I: 1:800-1:2200
Imaging: sac well perfused(i/c/t avascular aborting GS)
USG criteria:
Trophoblast located b/w blader and anterior abdominal wall
Fetal pole absent in uterine cavity
Sagittal view through amniotic sac no myometrium b/w GS and bladder
Lack of continuity of anterior uterine wall
Management: no role of expectant mgt –risk- uterine rupture
MTX, Hysteroscopic resection, uterus preserving wedge resection, hysterectomy
Pregnancy after hysterectomy
Supracervicalhysterectomy provides cervical canal intraperitoneal access
Pregnancy in periop period with implantation of already fertilized ovum in tube
After TAH secondary to vaginal mucosal defect that allows sperm into abdominal cavity
Twin/multiple ectopic pregnancies- less frequent
Variety of locations and combinations
ART
Treatment: similar to others
Multiple ectopic pregnancy
• In comparing systemic methotrexate with tube-sparing laparoscopic surgery, randomized trials have shown no difference in overall tubal preservation, tubal patency, repeat ectopic pregnancy, or future pregnancies
good and consistent evidence
(Level A):
• An increase in serum hCG of < 53% in 48 hr confirms an abnormal pregnancy.
• With an hCG level of > 5,000 mIU/mL, multiple doses MTX may be appropriate.
• MTX can be considered in those women with a confirmed, or high clinical suspicion of, ectopic pregnancy who are hemodynamically stable with an unruptured mass.
• Failure of the hCG level to decrease by at least 15% from day 4 to day 7 after MTX administration treatment failure requiring therapy with either additional MTX / surgical intervention.
• Post-treatment hCG levels monitored until a nonpregnancylevel is reached
limited or inconsistent evidence
(Level B):
• If the initial hCG level is less than 200 mU/mL, 88% of patients experience spontaneous resolution.
consensus and expert opinion (Level C):
Surgical management of tubal pregnancy laparoscopic approach to the surgical management of tubal
pregnancy, in the haemodynamically stable patient, is preferable to an open approach.( A: evidence Ia)
Management of tubal pregnancy in the presence of haemodynamic instability should be by the most expedient method. In most cases this will be laparotomy.( C:evidenceIV)
In the presence of a healthy contralateral tube there is no clear evidence that salpingotomy should be used in preference to salpingectomy(B:EvidenceIIa).
Laparoscopic salpingotomy should be considered as the primary treatment when managing tubal pregnancy in the presence of contralateral tubal disease and the desire for future fertility. (B:EvidenceIIa).
Medical management of tubal pregnancy Medical therapy should be offered to suitable women, and units
should have treatment and follow-up protocols for the use of methotrexate in the treatment of ectopic pregnancy(B:EvidenceIIa)..
If medical therapy is offered, women should be given clear information (preferably written) about the possible need for further treatment and adverse effects following treatment. Women should be able to return easily for assessment at any time during follow-up. (B:EvidenceIIa).
Women most suitable for methotrexate therapy are those with a serum hCG below 3000 iu/l, and minimal symptoms. (B:EvidenceIIa).
Outpatient medical therapy with single-dose methotrexate is associated with a saving in treatment (A: evidenceIb)
Expectant management of pregnancy of unknown location
Expectant management is an option for clinically stable women with minimal symptoms and a pregnancy of unknown location. (C:EvidenceIII)
Expectant management is an option for clinically stable asymptomatic women with an ultrasound diagnosis of ectopic pregnancy and a decreasing serum hCG, initially less than serum 1000 iu/l. (C:EvidenceIII)
Persistent trophoblast
When salpingotomy is used for the management of tubal pregnancy, protocols should be in place for the identification and treatment of women with persistent trophoblast.( EvidenceIV)
Anti-D immunoglobulin
Nonsensitised women who are rhesus negative with a confirmed or suspected ectopic pregnancy should receive anti-D immunoglobulin. .( EvidenceIV)
Patient involvement
Women should be carefully advised, whenever possible, of the advantages and disadvantages associated with each approach used for the treatment of ectopic pregnancy. They should participate fully in the selection of the most appropriate treatment. .( EvidenceIV)
THANK YOU